m+Medelevator.RU
← Поиск публикаций
Advanced materials (Deerfield Beach, Fla.) · 2026

Bio-hybrid Nanostructures Orchestrate Photodynamic Remodeling of the Fusobacterium nucleatum-Associated Colorectal Tumor Niche.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Tao Maliang, Wei Binbin, Yang Ye, Zou Hang, Xiao Yanxuan, Xu Jiannan, Feng Junjie, He Bairong, Zhong Yuan, Yu Yixuan, Du Jiale, Huang Ziliang, Tang Ben Zhong, Zheng Lei, Situ Bo

Аннотация

The intratumoral microbiota acts as a microbial immune checkpoint in colorectal cancer (CRC), yet current strategies either kill silently without immune activation or permit bacterial rebound through incomplete targeting. Here we report a bio-hybrid assembly designed to synchronize the eradication of CRC cells and their tumor-associated Fusobacterium nucleatum. This system integrates a hemoglobin (Hb)-augmented aggregation-induced emission (AIE) photosensitizing module into cRGD-functionalized ginger-derived vesicles. This architecture couples Hb-associated oxygen availability with molecular confinement of the photosensitizer while harnessing the intrinsic anti-inflammatory components of the plant carrier to mitigate off-target toxicity. Light activation initiates a dual cascade: it induces lysosomal pyroptosis in malignant cells and disrupts key F. nucleatum pathways related to membrane transport and DNA repair. This synchronized killing elicits the coordinated release of damage- and pathogen-associated molecular patterns (PAMPs), effectively transforming an immunologically cold tumor into a robust in situ vaccine that drives dendritic cell maturation and systemic T-cell immunity. Our findings demonstrate that the integration of natural bioactivity with supramolecular engineering provides a biocompatible strategy for coordinated tumor-bacterial disruption and immunogenic remodeling of the F. nucleatum-associated tumor niche in CRC.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты